title: Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer.
abstract: Lung cancer is the most common cause of cancer mortality in male and female patients in the US. Although it is clear that tobacco smoking is a major cause of lung cancer, about half of all women with lung cancer worldwide are never-smokers. Despite a declining smoking population, the incidence of non-small cell lung cancer (NSCLC), the predominant form of lung cancer, has reached epidemic proportions particularly in women. Emerging data suggest that factors other than tobacco, namely endogenous and exogenous female sex hormones, have a role in stimulating NSCLC progression. Aromatase, a key enzyme for estrogen biosynthesis, is expressed in NSCLC. Clinical data show that women with high levels of tumor aromatase (and high intratumoral estrogen) have worse survival than those with low aromatase. The present and previous studies also reveal significant expression and activity of estrogen receptors (ERα, ERβ) in both extranuclear and nuclear sites in most NSCLC. We now report further on the expression of progesterone receptor (PR) transcripts and protein in NSCLC. PR transcripts were significantly lower in cancerous as compared to non-malignant tissue. Using immunohistochemistry, expression of PR was observed in the nucleus and/or extranuclear compartments in the majority of human tumor specimens examined. Combinations of estrogen and progestins administered in vitro cooperate in promoting tumor secretion of vascular endothelial growth factor and, consequently, support tumor-associated angiogenesis. Further, dual treatment with estradiol and progestin increased the numbers of putative tumor stem/progenitor cells. Thus, ER- and/or PR-targeted therapies may offer new approaches to manage NSCLC.
authors: Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
authors: Diana C
authors: DC
authors: Marquez-Garban
authors: Vei
authors: V
authors: Mah
authors: Mohammad
authors: M
authors: Alavi
authors: Erin L
authors: EL
authors: Maresh
authors: Hsiao-Wang
authors: HW
authors: Chen
authors: Lora
authors: L
authors: Bagryanova
authors: Steve
authors: S
authors: Horvath
authors: David
authors: D
authors: Chia
authors: Edward
authors: E
authors: Garon
authors: Lee
authors: L
authors: Goodglick
authors: Richard J
authors: RJ
authors: Pietras
references: Nature. 2010 Jun 10;465(7299):803-7
references: 20445538
references: Nature. 2010 Jun 10;465(7299):798-802
references: 20383121
references: J Natl Cancer Inst. 2010 Sep 22;102(18):1413-21
references: 20709992
references: Am J Pathol. 1997 Dec;151(6):1523-30
references: 9403702
references: Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L222-8
references: 17449797
references: Cancer Res. 2010 Aug 15;70(16):6639-48
references: 20710044
references: Cancer Res. 2005 Dec 15;65(24):11287-91
references: 16357134
references: Lung Cancer. 2002 Aug;37(2):153-9
references: 12140138
references: Cancer Res. 2005 Feb 15;65(4):1598-605
references: 15735050
references: Clin Cancer Res. 2009 Nov 15;15(22):6820-9
references: 19887480
references: FASEB J. 2000 Jan;14(1):157-65
references: 10627290
references: Mol Cancer Res. 2009 Mar;7(3):330-8
references: 19276181
references: Anticancer Res. 1996 Nov-Dec;16(6B):3803-6
references: 9042261
references: Breast J. 2003 Sep-Oct;9(5):361-73
references: 12968955
references: J Clin Oncol. 2006 Jan 1;24(1):59-63
references: 16314616
references: J Steroid Biochem Mol Biol. 2009 Aug;116(1-2):102-9
references: 19460433
references: J Natl Cancer Inst. 1994 Jun 1;86(11):869-70
references: 8182770
references: Clin Cancer Res. 2011 Jan 1;17(1):154-64
references: 21062926
references: Am J Respir Crit Care Med. 2010 Jul 1;182(1):62-72
references: 20378727
references: Semin Oncol. 2002 Dec;29(6 Suppl 16):10-4
references: 12516033
references: Cancer Res. 2010 Dec 1;70(23):9969-78
references: 21098716
references: Steroids. 2008 Oct;73(9-10):870-3
references: 18289622
references: Mol Cell Endocrinol. 2006 Feb 26;246(1-2):91-100
references: 16388889
references: J Intern Med. 2008 Aug;264(2):128-42
references: 18513343
references: Mol Endocrinol. 1999 Feb;13(2):307-19
references: 9973260
references: Gynecol Oncol. 2005 Jan;96(1):32-41
references: 15589577
references: J Clin Oncol. 2007 Feb 10;25(5):561-70
references: 17290066
references: Cancer Res. 1985 Sep;45(9):4206-14
references: 3875407
references: BMC Cancer. 2010 Jun 28;10:335
references: 20584319
references: N Engl J Med. 2002 Jan 31;346(5):340-52
references: 11821512
references: Clin Cancer Res. 2008 Jul 15;14(14):4417-26
references: 18579664
references: J Appl Physiol (1985). 2007 Nov;103(5):1789-95
references: 17717117
references: Steroids. 2008 Oct;73(9-10):922-8
references: 18321550
references: Anticancer Res. 2005 Nov-Dec;25(6C):4693-8
references: 16334162
references: Steroids. 2007 Feb;72(2):135-43
references: 17276470
references: Cell Stem Cell. 2007 Nov;1(5):555-67
references: 18371393
references: J Clin Oncol. 2006 Apr 10;24(11):1679-88
references: 16549822
references: JAMA. 2004 Apr 14;291(14):1763-8
references: 15082704
references: Int J Pediatr. 2009;2009:170491
references: 19946415
references: Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1032-7
references: 10655479
references: PLoS One. 2008 Aug 27;3(8):e3077
references: 18728788
references: Mol Endocrinol. 2009 Feb;23(2):146-56
references: 19106194
references: Endocrinology. 2005 Aug;146(8):3632-41
references: 15845615
references: Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2076-81
references: 14764897
references: Clin Cancer Res. 2009 Sep 1;15(17):5359-68
references: 19706809
references: Lung Cancer. 2008 Jan;59(1):88-94
references: 17905466
references: Mol Cell Endocrinol. 2002 Feb 25;188(1-2):125-40
references: 11911952
references: Nat Med. 1995 Jan;1(1):27-31
references: 7584949
references: Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):113-23
references: 14734459
references: Adv Exp Med Biol. 2008;617:377-84
references: 18497061
references: Cancer Res. 2007 Nov 1;67(21):10484-90
references: 17974992
references: Steroids. 2005 May-Jun;70(5-7):372-81
references: 15862820
references: Hum Pathol. 2010 Feb;41(2):190-8
references: 19800101
references: Exp Clin Endocrinol Diabetes. 1998;106(4):334-9
references: 9792467
references: Cancer Res. 2002 Apr 1;62(7):2141-50
references: 11929836
references: PLoS One. 2010 Mar 09;5(3):e9584
references: 20231893
references: Eur J Cardiothorac Surg. 2009 Sep;36(3):446-53
references: 19464919
references: Mol Endocrinol. 1997 Oct;11(11):1593-607
references: 9328342
references: J Natl Compr Canc Netw. 2009 Sep;7 Suppl 6:S1-S21; quiz S22-3
references: 19755043
references: PLoS One. 2008 Jul 09;3(7):e2637
references: 18612434
references: Anticancer Res. 2010 Jan;30(1):119-22
references: 20150625
references: Lancet. 2009 Oct 10;374(9697):1243-51
references: 19767090
references: Lung Cancer. 2009 Jan;63(1):1-9
references: 18579254
references: J Clin Oncol. 2010 Mar 20;28(9):1540-6
references: 20159813
references: Stem Cells. 2010 Apr;28(4):649-60
references: 20178109
references: Oncol Rep. 2007 Sep;18(3):685-90
references: 17671720
references: JAMA. 1973 Nov 5;226(6):652-7
references: 4356847
references: Arch Pathol Lab Med. 2000 Oct;124(10):1467-70
references: 11035577
references: Cancer Res. 2005 Feb 15;65(4):1459-70
references: 15735034
references: Oncogene. 2002 Apr 25;21(18):2805-14
references: 11973639
references: Genes Dev. 2003 May 15;17(10):1253-70
references: 12756227
references: Oncogene. 2008 Oct 16;27(47):6120-30
references: 18591932
references: Clin Cancer Res. 2007 Aug 15;13(16):4672-6
references: 17699844
references: Cancer Res. 2005 Jul 15;65(14):6450-8
references: 16024650
references: J Thorac Oncol. 2009 Sep;4(9):1094-103
references: 19687765
references: J Clin Oncol. 2010 Jun 1;28(16):2784-95
references: 20404251